A Refreshed AI & ML Focus Day
The interest in AI & ML applications in GPCR-targeted drug discovery is accelerating, but many uncertainties remain. As the field pushes toward deeper computational integration, key questions continue to shape the path forward, including:
- Can AI accurately predict GPCR structure, dynamics, and conformational flexibility?
- To what extent can AI model ligand-GPCR interactions across modalities?
- Can AI enhance target deconvolution and reveal new druggable GPCRs?
- How do we overcome data scarcity, bias, and low-quality datasets?
- Can AI design GPCR-biased ligands or predict signaling outcomes?
- What is required to build validated, interpretable, regulatory-ready models?
- How reliably can AI integrate structural, pharmacological, and dynamic data?
Our speakers will address these challenges throughout the day, with a panel discussion providing an opportunity to ask your own questions on the future of AI in GPCR drug discovery.
Real-World Translation Stories
In 2026, we're shining a spotlight on the translational breakthroughs moving GPCR-targeted therapeutics from discovery toward clinical reality. Learn how experts are engineering long-acting molecules, refining polypharmacology, leveraging systems biology, and deploying biomarker-driven strategies to de-risk and accelerate clinical development.
Explore The Full Event Guide
- 80+ Attendees
- 25+ World-Class Speakers
- 21+ Data-Driven Presentations
- 7+ Hours of Networking
- 1 AI & ML Focus Day
Attending Companies Include
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug discovery and make critical connections during our dedicated networking sessions
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.